Chorionic Gonadotropin: Clinical Trials

22 trials of Chorionic Gonadotropin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 5 terminated, 4 unknown, 2 withdrawn. 22 Phase 2, 7 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 222Completed 9, Terminated 5, Unknown 4, Withdrawn 2, Enrolling by invitation 1, Recruiting 1
Phase 17Completed 5, Terminated 1, Unknown 1
Phase 31Completed 1

Follow Chorionic Gonadotropin: new trials by email Literature Review of Chorionic Gonadotropin trials Research Report on Chorionic Gonadotropin

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm
isotretinoin, Human chorionic gonadotrophin (hCG) - Oligospermia, Azoospermia, Nonobstructive
Phase 2Enrolling by invitationUniversity of Nebraska1002026-04-132026-04-20
Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment
Human chorionic gonadotropin (hCG), Prednisone, Dexamethasone - Acute Graft Versus Host Disease
Phase 2RecruitingHospital Universitario Dr. Jose E. Gonzalez202025-02-012025-04-03
Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
Ruxolitinib 10 MG Oral Tablet, hCG, Corticosteroids - Acute-graft-versus-host Disease
Phase 1 / Phase 2TerminatedMasonic Cancer Center, University of Minnesota102023-06-052026-03-24
Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation
FE 999302, Ovitrelle, Novarel - Infertility
Phase 2WithdrawnFerring Pharmaceuticals2022-10-042023-01-09
Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men
Lutropin alfa, Human chorionic gonadotropin - Acquired Hypogonadotropic Hypogonadism
Phase 2UnknownAzienda Ospedaliero-Universitaria di Modena322022-01-192023-07-20
ITT-5 Mechanisms of Spermatogenesis in Man
Testosterone 1% Gel, Acyline, Dutasteride - Gonadotropin Deficiency
Phase 2WithdrawnUniversity of Washington2019-06-012019-12-18
Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility
Human Chorionic Gonadotropin (hCG), Gonadotropins, GNRH-A Triptorelin - Female Infertility, Female Infertility Due to Ovulatory Disorder
Phase 1 / Phase 2CompletedLebanese University2002018-02-012023-05-09
Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
Pregnyl® - Graft vs Host Disease
Phase 1 / Phase 2CompletedMasonic Cancer Center, University of Minnesota532016-03-012023-12-14
GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia
GnRHa/ hCG/ hMG - Azoospermia
Phase 2UnknownJinling Hospital, China302015-12-012016-08-02
Letrozole Versus Clomiphene Citrate for Ovulation Induction in Women With Poly Cystic Ovary Syndrome ( PCOS )
Letrozole, Clomiphene citrate, hcg hormone - Anovulation, Polycystic Ovary Syndrome
Phase 2Unknownmostafa gomaa hamid halawa1102015-10-012015-09-16
Human Chorionic Gonadotrophin in an Antagonist Protocol
Low dose HCG, Placebo - Infertility
Phase 2 / Phase 3CompletedCairo University602013-08-012015-02-03
Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD)
Human Chorionic Gonadotropin, Placebo, Low calorie diet - HCG
Phase 1 / Phase 2CompletedDr. Emma's Corporation592011-05-012015-04-28
Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome
low dose human chorionic gonadotropin, Clomiphen citrate plus HMG - Endocrine System Diseases, Gonadal Disorders
Phase 1 / Phase 2CompletedRoyan Institute102009-08-012011-07-15
Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients
human chorionic gonadotropin (hCG), then epoetin alfa (EPO), Saline Placebo - Stroke
Phase 2TerminatedStem Cell Therapeutics Corp.962009-08-012011-11-29
HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
Acyline, placebo hCG (no active ingredient), hCG (human chorionic gonadotropin) - Healthy Males
Phase 1 / Phase 2CompletedUniversity of Washington592009-03-012016-01-11
Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification
freezing embryos by vitrification, fresh embryo transfers, buserelin - In Vitro Fertilization
Phase 1 / Phase 2UnknownYazd Research & Clinical Center for Infertility5002008-08-012010-01-20
AS900672-Enriched in Ovulation Induction
AS900672-Enriched 10 microgram (mcg), AS900672-Enriched 20 mcg, AS900672-Enriched 30 mcg - Ovulation Induction
Phase 2TerminatedMerck KGaA, Darmstadt, Germany712007-12-012014-02-13
A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age
r-hLH + r-hFSH, r-hFSH, Recombinant Human Choriogonadotropin (r-hCG) - Infertility, Ovulation Induction
Phase 2TerminatedMerck KGaA, Darmstadt, Germany932007-11-012014-02-27
A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)
corifollitropin alfa, recombinant Follicle Stimulating Hormone (recFSH), human Chorion Gonadotropin (hCG) - Ovulation Induction
Phase 2TerminatedOrganon and Co82007-05-152024-06-17
Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)
AS900672-Enriched 50 microgram (mcg), AS900672-Enriched 100 mcg, AS900672-Enriched 150 mcg - Infertility
Phase 2CompletedMerck KGaA, Darmstadt, Germany5202007-01-012014-02-13

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Infertility (8)  ·  Polycystic Ovary Syndrome (3)  ·  Azoospermia, Nonobstructive (2)  ·  Hypogonadism (2)  ·  Infertility, Male (2)  ·  Anovulation (1)  ·  Azoospermia (1)  ·  Endocrine System Diseases (1)  ·  Endometriosis (1)  ·  Endometritis (1)  ·  Gonadal Disorders (1)  ·  Graft vs Host Disease (1)  ·  Helping Behavior (1)  ·  Hypertrichosis congenital generalized X-linked (1)  ·  Infertility, Female (1)

Sponsors

Merck KGaA, Darmstadt, Germany (3)  ·  Masonic Cancer Center, University of Minnesota (2)  ·  Organon and Co (2)  ·  University of Washington (2)  ·  Azienda Ospedaliero-Universitaria di Modena (1)  ·  Cairo University (1)  ·  Dr. Emma's Corporation (1)  ·  Ferring Pharmaceuticals (1)  ·  Hadassah Medical Organization (1)  ·  Hospital Universitario Dr. Jose E. Gonzalez (1)  ·  Jinling Hospital, China (1)  ·  Lebanese University (1)  ·  Royan Institute (1)  ·  Stem Cell Therapeutics Corp. (1)  ·  University of Nebraska (1)

Countries

United States (8)  ·  Iran (2)  ·  Spain (2)  ·  Canada (1)  ·  China (1)  ·  Egypt (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Lebanon (1)  ·  Mexico (1)  ·  Switzerland (1)

Top investigators

Antonio Pellicer, Professor Dr (1)  ·  Assaf Ben-Meir, MD (1)  ·  Bing Yao, MD (1)  ·  Chris Deibert, MD, MPH (1)  ·  Mahnaz Ashrafi (1)  ·  Mara Roth, MD (1)  ·  Michael D Hill, MD (1)  ·  Nehman Makdissy, Professor (1)  ·  Samar El Hamoui, Dr (1)  ·  Sherman Holtan, MD (1)  ·  Shernan Holtan, MD (1)  ·  Steven C Cramer, MD (1)  ·  William Bremner, MD, PhD (1)

Results publications

PMID 15126522, PMID 20373015, PMID 20484472, PMID 23040523, PMID 24588854, PMID 30243299, PMID 32236525, PMID 37279855

NIH funding

U54HD012629 (1)